News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
Patients It’s time to do better for patients with rare neurological d... Global Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to clinical trials for all patients with rare CNS conditions.
Events Partner Content 3rd Annual Blood-Brain Barrier Summit Enhance Drug Delivery Across the Blood-Brain Barrier
Partner Content Partner Content The 3rd Annual Blood-Brain Barrier Summit Returns in August ... Specialized Digital Conference for Biopharma
Events Partner Content 2nd Gene Therapy for Neurological Disorders Europe Maximising the Opportunity in CNS Gene Therapies
Views & Analysis Nine for 2021: Addressing the pandemic legacy In this second 'Nine for 2021' article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact pharma in 2021: t
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
